Rapid Dose Therapeutics Corp. DOSE
CNSX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -568.70K | -366.60K | -509.40K | -816.90K | -601.80K |
| Total Depreciation and Amortization | 84.80K | 87.60K | 85.80K | 90.70K | 98.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 148.10K | 150.00K | 35.00K | 497.60K | 209.00K |
| Change in Net Operating Assets | 328.50K | 161.20K | 824.50K | 37.60K | 47.20K |
| Cash from Operations | -7.40K | 32.10K | 435.90K | -191.10K | -247.00K |
| Capital Expenditure | -- | -- | 0.00 | -- | -700.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.85M | -- | -- |
| Cash from Investing | -- | -- | 1.85M | -- | -700.00 |
| Total Debt Issued | 62.00K | 15.00K | -2.48M | 360.60K | 221.50K |
| Total Debt Repaid | -57.70K | -56.00K | -387.20K | -57.20K | -45.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -377.60K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00K |
| Cash from Financing | 3.10K | -29.90K | -2.36M | 217.30K | 201.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 45.80K | -- |
| Net Change in Cash | -4.30K | 2.30K | -71.00K | 72.10K | -46.60K |